NKG7 Is a T-cell-Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy

CANCER IMMUNOLOGY RESEARCH

AMER ASSOC CANCER RESEARCH

1. Mayo Clinic benefactors
2. Mayo Clinic Center for Individualized Medicine's IMPRESS program
3. High-Definition Therapeutics program
4. Mayo Clinic Center for Biomedical Discovery
5. Mayo Clinic Cancer Center's David F. and Margaret T. Grohne Cancer Immunology and Immunotherapy program
6. Richard M. Schulze Family Foundation
7. Innovation Accelerator Awards program of the Office of Translation to Practice (OTP) at the Mayo Clinic Center for Clinical and Translational Science (CCaTS)
8. NIH [R01 CA256927, F30 CA250122, F30 CA250326, R21 CA251923, K12 CA 090628, R21 CA197878, R01 CA200551, R01 AI095239]
9. National Institute of General Medical Sciences [T32 GM65841]